145 related articles for article (PubMed ID: 22542076)
1. Role of alpha methylacyl-coenzyme A racemase in differentiating hepatocellular carcinoma from dysplastic and nondysplastic liver cell lesions.
Helal Tel A; Radwan NA; Abdel Kader Z; Helmy NA; Hammad SY
Ann Diagn Pathol; 2012 Oct; 16(5):330-4. PubMed ID: 22542076
[TBL] [Abstract][Full Text] [Related]
2. Alpha-methylacyl-CoA racemase (AMACR/P504S) can distinguish hepatocellular carcinoma and dysplastic hepatocytes from benign nondysplastic hepatocytes.
Guzman G; Wu SJ; Kajdacsy-Balla A; Cotler SJ
Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):411-6. PubMed ID: 17122637
[TBL] [Abstract][Full Text] [Related]
3. Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma.
Li W; Cagle PT; Botero RC; Liang JJ; Zhang Z; Tan D
J Exp Clin Cancer Res; 2008 May; 27(1):2. PubMed ID: 18577240
[TBL] [Abstract][Full Text] [Related]
4. AMACR is not applicable as a diagnostic tool in hepatocellular carcinoma.
Willemoe GL; Vainer B
APMIS; 2010 Feb; 118(2):85-90. PubMed ID: 20132171
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of α-methylacyl-CoA racemase is associated with CTNNB1 mutations in hepatocellular carcinomas.
Sekine S; Ogawa R; Ojima H; Kanai Y
Histopathology; 2011 Apr; 58(5):712-9. PubMed ID: 21457159
[TBL] [Abstract][Full Text] [Related]
6. Alpha-methylacyl-CoA-racemase expression in adenocarcinoma, dysplasia and non-neoplastic epithelium of the stomach.
Lee WA
Oncology; 2006; 71(3-4):246-50. PubMed ID: 17652945
[TBL] [Abstract][Full Text] [Related]
7. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
Dorer R; Odze RD
Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
[TBL] [Abstract][Full Text] [Related]
8. Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel disease.
Marx A; Wandrey T; Simon P; Wewer A; Grob T; Reichelt U; Minner S; Simon R; Spehlmann M; Tigges W; Soehendra N; Seitz U; Seewald S; Izbicki JR; Yekebas E; Kaifi JT; Mirlacher M; Terracciano L; Fleischmann A; Raedler A; Sauter G
Hum Pathol; 2009 Feb; 40(2):166-73. PubMed ID: 18835622
[TBL] [Abstract][Full Text] [Related]
9. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
[TBL] [Abstract][Full Text] [Related]
10. Alpha-methylacyl-CoA racemase (AMACR) in fine-needle aspiration specimens of prostate lesions.
Kaić G; Tomasović-Loncarić C
Diagn Cytopathol; 2009 Nov; 37(11):803-8. PubMed ID: 19459159
[TBL] [Abstract][Full Text] [Related]
11. Alpha-methylacyl coenzyme A racemase overexpression in gallbladder carcinoma confers an independent prognostic indicator.
Wu LC; Chen LT; Tsai YJ; Lin CM; Lin CY; Tian YF; Sheu MJ; Uen YH; Shiue YL; Wang YH; Yang SJ; Wu WR; Li SH; Iwamuro M; Kobayasshi N; Huang HY; Li CF
J Clin Pathol; 2012 Apr; 65(4):309-14. PubMed ID: 22267983
[TBL] [Abstract][Full Text] [Related]
12. Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas.
Wang XY; Degos F; Dubois S; Tessiore S; Allegretta M; Guttmann RD; Jothy S; Belghiti J; Bedossa P; Paradis V
Hum Pathol; 2006 Nov; 37(11):1435-41. PubMed ID: 16949914
[TBL] [Abstract][Full Text] [Related]
13. α-Methylacyl-CoA racemase (P504S) is a useful marker for the differential diagnosis of solid pseudopapillary neoplasm of the pancreas.
Shen Y; Wang Z; Zhu J; Chen Y; Gu W; Liu Q
Ann Diagn Pathol; 2014 Jun; 18(3):146-50. PubMed ID: 24675392
[TBL] [Abstract][Full Text] [Related]
14. Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer.
Ananthanarayanan V; Deaton RJ; Yang XJ; Pins MR; Gann PH
Prostate; 2005 Jun; 63(4):341-6. PubMed ID: 15602744
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
Herawi M; Epstein JI
Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
[TBL] [Abstract][Full Text] [Related]
17. Is atypical adenomatous hyperplasia of the prostate a precursor lesion?
Zhang C; Montironi R; MacLennan GT; Lopez-Beltran A; Li Y; Tan PH; Wang M; Zhang S; Iczkowski KA; Cheng L
Prostate; 2011 Dec; 71(16):1746-51. PubMed ID: 21480308
[TBL] [Abstract][Full Text] [Related]
18. A study of indefinite for dysplasia in Barrett's oesophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (alpha-methylacyl-CoA-racemase).
Sonwalkar SA; Rotimi O; Scott N; Verghese E; Dixon M; Axon AT; Everett SM
Histopathology; 2010 Jun; 56(7):900-7. PubMed ID: 20636793
[TBL] [Abstract][Full Text] [Related]
19. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).
Jiang Z; Woda BA; Wu CL; Yang XJ
Am J Clin Pathol; 2004 Aug; 122(2):275-89. PubMed ID: 15323145
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of alpha-methylacyl-coenzyme A racemase in prostatic adenocarcinoma following hormone therapy.
Suzue K; Montag AG; Tretiakova M; Yang XJ; Sahoo S
Am J Clin Pathol; 2005 Apr; 123(4):553-61. PubMed ID: 15743746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
